Literature DB >> 2829753

Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.

K Fogh1, J Kiil, T Herlin, T Ternowitz, K Kragballe.   

Abstract

Several biologically active lipoxygenase products or arachidonic acid (AA) have been demonstrated in psoriatic skin lesions. The purpose of the present study was to determine the amounts of the different lipoxygenase products simultaneously in psoriatic skin. Slices of psoriatic skin were obtained at different levels with a keratome. Extracted lipids were identified by high performance liquid chromatography, UV-absorption spectrum, radioimmunoassay, and chemokinesis. Leukotriene B4 (LTB4), and 12- and 15-hydroxy-eicosatetraenoic acid (HETE) were detected in most psoriatic lesions. However, there was a remarkable variation from lesion to lesion. The biopsy specimens contained: 276.2 +/- 126.0 pg/g wet tissue of LTB4, 3,130.0 +/- 2,898.0 ng/g wet tissue of 12-HETE, and 3,633.0 +/- 1,692.0 ng/g wet tissue of 15-HETE. No correlation was found between the levels of the different lipoxygenase products. The content of each of the identified lipoxygenase products was higher in the superficial part of the biopsy specimen consisting of approximately two-thirds of the epidermis plus papillary dermis than in the lower part consisting of approximately one-third of the epidermis plus some reticular dermis. Also, there was a great variation from one anatomical region to another within the same patient. Because these lipoxygenase products possess different biological activities, the variation in their occurrence may be important for understanding their potential role in psoriasis. To determine which lipoxygenase products may be of pathogenic importance, analysis of early psoriatic lesions is warranted.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829753     DOI: 10.1007/BF00413280

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  23 in total

1.  Dermis-derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity.

Authors:  K Kragballe; G Pinnamaneni; L Desjarlais; E A Duell; J J Voorhees
Journal:  J Invest Dermatol       Date:  1986-10       Impact factor: 8.551

2.  In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.

Authors:  K Kragballe; L Desjarlais; E A Duell; J J Voorhees
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

3.  Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions.

Authors:  P M Woollard
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

4.  Leukotrienes C4 and D4 in psoriatic skin lesions.

Authors:  S D Brain; R D Camp; A K Black; P M Dowd; M W Greaves; A W Ford-Hutchinson; S Charleson
Journal:  Prostaglandins       Date:  1985-04

5.  Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.

Authors:  T Ruzicka; T Simmet; B A Peskar; J Ring
Journal:  J Invest Dermatol       Date:  1986-02       Impact factor: 8.551

6.  Surgical treatment of psoriasis.

Authors:  J Kiil; J Kiil; H Søgaard
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

7.  Role of oxygen in antibody-dependent cytotoxicity mediated by monocytes and neutrophils.

Authors:  N Borregaard; K Kragballe
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

8.  The identification of hydroxy fatty acids in psoriatic skin.

Authors:  R D Camp; A I Mallet; P M Woollard; S D Brain; A K Black; M W Greaves
Journal:  Prostaglandins       Date:  1983-09

9.  Leukotriene B4 and 12-hydroxyeicosatetraenoic acid stimulate epidermal proliferation in vivo in the guinea pig.

Authors:  C C Chan; L Duhamel; A Ford-Hutchison
Journal:  J Invest Dermatol       Date:  1985-10       Impact factor: 8.551

10.  Selective expression of 15-lipoxygenase activity by cultured human keratinocytes.

Authors:  B A Burrall; B U Wintroub; E J Goetzl
Journal:  Biochem Biophys Res Commun       Date:  1985-11-27       Impact factor: 3.575

View more
  8 in total

1.  Effect of auranofin on eicosanoids and protein kinase C in human neutrophils.

Authors:  T Herlin; K Fogh; N O Christiansen; K Kragballe
Journal:  Agents Actions       Date:  1989-08

2.  LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin.

Authors:  L Iversen; B Deleuran; A M Hoberg; K Kragballe
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

3.  In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.

Authors:  K Fogh; T Herlin; K Kragballe
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Diversity of mouse lipoxygenases: identification of a subfamily of epidermal isozymes exhibiting a differentiation-dependent mRNA expression pattern.

Authors:  M Heidt; G Fürstenberger; S Vogel; F Marks; P Krieg
Journal:  Lipids       Date:  2000-07       Impact factor: 1.880

5.  Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin.

Authors:  B Grøn; L Iversen; V Ziboh; K Kragballe
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 6.  Leukotriene B4 and platelet-activating factor in human skin.

Authors:  L Michel; L Dubertret
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

7.  Supplementation with evening primrose oil in atopic dermatitis: effect on fatty acids in neutrophils and epidermis.

Authors:  L Schäfer; K Kragballe
Journal:  Lipids       Date:  1991-07       Impact factor: 1.880

8.  Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.

Authors:  D J Fretland; C P Anglin; M Bremer; P Isakson; D L Widomski; S K Paulson; S H Docter; S W Djuric; T D Penning; S Yu
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.